Pyridopyrazines and the use thereof as kinase inhibitors

US8193186B2 · kind B2 · utility

Assignee

• Aeterna Zentaris, Inc. · DE

Inventors

• Irene Seipelt · Offenbach, DE
• Ulf Rapp · Würzburg, DE
• Ludmilla Wixler · Coburg, DE
• Eckhard Claus · Frankfurt, DE
• Eckhard Gunther · Offenbach, DE

Key dates

• Filing date: Jul 5, 2007
• Grant date: Jun 5, 2012
• Expiry date: Jul 2, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general Formula I, their preparation and use as medicaments, in particular for the treatment of malignant and other disorders based on pathological cell proliferations.